← Leaderboards
Kristina Fontanez
Fluent Biosciences Inc.
$4,627,729
Attributed
$5,742,910
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,742,910 · 5
By mechanism
R44$5,055,486 · 3
R43$687,424 · 2
Top collaborators
- Tony E Godfrey3 shared
Others in their field
Other Emerging Leaders on “Biological Sciences”
- Leonard Freedman · Leidos Biomedical Research, Inc.$303,358,627
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$197,638,955
- Lynn Briscoe · Leidos Biomedical Research, Inc.$121,890,535
- Leonard Freedmand · Leidos Biomedical Research, Inc.$57,401,321
- Sujatha Rashid · American Type Culture Collection$47,750,404
Research focus
Biological SciencesLibrariesSamplingMicrofluidicsCellsTechnologyGenomicsCostMalignant NeoplasmsPreparationInsightCost EffectiveProtocols DocumentationComplexBar CodesPerformanceFlexibilityInstrumentationReactionBaseCollaborationsInformaticsIndexingInnovation
Grant awards (8)
Commercialization of methods and reagents for high-throughput single cell analysis$1,146,224
R44 · FY2023 · GM · contact PI
New tools for highly accessible single cell RNA sequencing$775,245
R44 · FY2023 · GM · contact PI
New tools for highly accessible single cell RNA sequencing$903,654
R44 · FY2022 · GM · contact PI
Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq$825,632
R44 · FY2021 · CA · contact PI
Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq$1,105,490
R44 · FY2020 · CA · contact PI
PIPsceq: powering single cell RNA sequencing into the million cell era$399,059
R43 · FY2020 · GM · contact PI
Custom assays for personalized, longitudinal monitoring of circulating tumor DNA using PIPSenSeq$299,241
R44 · FY2019 · CA · contact PI
Anti-cancer drug screening enabled by Pre-templated Instant Partitions and single cell RNA sequencing$288,365
R43 · FY2019 · CA · contact PI